CNR Institutional Research Information System

ZUCCA, FABIO ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.179
NA - Nord America 1.041
SA - Sud America 426
EU - Europa 387
AF - Africa 37
OC - Oceania 3
Totale 4.073
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 991
SG - Singapore 906
CN - Cina 528
BR - Brasile 349
VN - Vietnam 274
HK - Hong Kong 203
FR - Francia 142
KR - Corea 85
IT - Italia 57
IN - India 54
DE - Germania 43
JP - Giappone 32
GB - Regno Unito 30
FI - Finlandia 26
AR - Argentina 25
CA - Canada 20
MX - Messico 18
ID - Indonesia 17
EC - Ecuador 14
NL - Olanda 13
CO - Colombia 12
ZA - Sudafrica 12
BD - Bangladesh 11
RU - Federazione Russa 11
ES - Italia 10
IL - Israele 10
IQ - Iraq 8
MA - Marocco 7
PY - Paraguay 7
UA - Ucraina 7
VE - Venezuela 7
PE - Perù 6
TR - Turchia 6
AZ - Azerbaigian 5
KE - Kenya 5
PL - Polonia 5
PT - Portogallo 5
SA - Arabia Saudita 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
IE - Irlanda 4
JO - Giordania 4
MY - Malesia 4
PA - Panama 4
RS - Serbia 4
SE - Svezia 4
CZ - Repubblica Ceca 3
NP - Nepal 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AT - Austria 2
CL - Cile 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PH - Filippine 2
RO - Romania 2
TH - Thailandia 2
TW - Taiwan 2
UZ - Uzbekistan 2
YT - Mayotte 2
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DJ - Gibuti 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PK - Pakistan 1
QA - Qatar 1
TG - Togo 1
TZ - Tanzania 1
Totale 4.073
Salva come PNG Salva come JPEG
Città #
Singapore 522
Santa Clara 403
Hefei 220
Hong Kong 197
San Jose 137
Ho Chi Minh City 104
Beijing 100
Lauterbourg 91
Seoul 84
Ashburn 66
Hanoi 59
Los Angeles 34
São Paulo 27
Dallas 26
Frankfurt am Main 22
Tokyo 19
Guangzhou 18
New York 18
Helsinki 17
Mumbai 12
Rio de Janeiro 12
Biên Hòa 10
Da Nang 10
Milan 10
Bengaluru 9
Buffalo 9
Minamishinagawa 9
Orem 9
Atlanta 8
Brasília 8
Johannesburg 8
Portsmouth 8
Belo Horizonte 7
Boston 7
Guayaquil 7
Quận Bình Thạnh 7
Turku 7
Brescia 6
Brooklyn 6
Curitiba 6
Düsseldorf 6
Guarulhos 6
Haiphong 6
Arese 5
Baku 5
Chicago 5
Duque de Caxias 5
Madrid 5
Manaus 5
Nuremberg 5
Phoenix 5
Porto Alegre 5
Ribeirão Preto 5
Salvador 5
Amman 4
Asunción 4
Birmingham 4
Buenos Aires 4
Campinas 4
Can Tho 4
Chennai 4
Dublin 4
Goiânia 4
Hyderabad 4
Kolkata 4
Lima 4
Nairobi 4
Queens 4
Bandung 3
Bexley 3
Bogotá 3
Bắc Giang 3
Delhi 3
Denver 3
Dhaka 3
Elk Grove Village 3
Erbil 3
Falkenstein 3
Formosa 3
Houston 3
Kuala Lumpur 3
Lisbon 3
Maceió 3
Manchester 3
Marseille 3
Milwaukee 3
Monza 3
Munich 3
Ninh Bình 3
Nitrianske Hrnčiarovce 3
Nova Iguaçu 3
Novara 3
Paris 3
Petrópolis 3
Phủ Lý 3
Prague 3
Riyadh 3
Sacramento 3
Shanghai 3
St Louis 3
Totale 2.564
Salva come PNG Salva come JPEG
Nome #
Engineered nanoparticles. How brain friendly is this new guest? 104
New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals 89
Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease. 82
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease 82
Overexpression of Vesicular Monoamine Transporter-2 may Block Neurotoxic Metabolites from Cytosolic Dopamine: a Potential Neuroprotective Therapy for Parkinson's Disease 82
Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson's Disease 75
Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders 70
Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells 68
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease 65
Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease 62
Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role 61
The neurobiology of human aggressive behavior: Neuroimaging, genetic, and neurochemical aspects 60
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. 59
The role of neuromelanins in the oxidative stress of Parkinson's disease. 58
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain 58
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease 57
Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models 56
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease 54
Convenient Synthetic Method Of Putative Degradative Markers To Identify Various Catecholic Metabolites In Addition To Dopamine And Norepinephrine Incorporated In Neuromelanin. 53
Synthesis, Structure Characterization, and Evaluation in Microglia Cultures of Neuromelanin Analogues Suitable for Modeling Parkinson's Disease 52
Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells 52
Neuromelanin a chelator of iron and other metals in catecholaminergic neurons of substantia nigra and locus coeruleus. 51
Neuromelanin of the Human Substantia Nigra: An Update 51
Water-Soluble Melanin-Protein-Fe/Cu Conjugates Derived from Norepinephrine as Reliable Models for Neuromelanin of Human Brain Locus Coeruleus 51
Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease 49
Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases 48
Neuromelanins Isolated from Different Regions of the Human Brain Exhibit a Common Surface Photoionization Threshold 47
Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type A 47
A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest 46
Contrast mechanisms associated with neuromelanin-MRI 46
Synthetic models of neuromelanin with fibrillated protein in the core 45
Neuromelanin organelle pathways in aging and neurodegeneration of Parkinson's Disease 45
A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease 44
IRON, COPPER AND THEIR MOLECULES IN SUBSTANTIA NIGRA OF NORMAL SUBJECTS DURING AGING 43
Melanic Pigments in the Human brain 43
Iron, Myelin, and the Brain: Neuroimaging Meets Neurobiology 43
The role of neuromelanin organelle pathways in parkinson's disease 42
NEUROMELANINS ACCUMULATE IN NEURONS DURING HUMAN BRAIN AGING AND BIND METALS 41
Neuromelanin organelles pathways in brain aging and Parkinson's disease 41
Neuromelanins in various regions of human brain are associated with native and oxidized isoprenoid lipids. 41
Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability. 41
The Role of Iron in Neurodegeneration 40
The surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surface. 40
Proteomic profile of neuromelanin and neuromelanin-containing organelles 40
Protective and toxic role of neuromelanin in brain aging and Parkinson's disease 38
Neuromelanin activates microglia and induces substantia nigra neuron death. A key mechanism of Parkinson's disease. 38
Protective and toxic roles of dopamine in Parkinson's disease 38
The structure of neuromelanin as studied by chemical degradative methods 37
Neuromelanins in brain aging and Parkinson's disease. 37
Protective and neurotoxic role of neuromelanin in human brain 37
Amyloid beta and neuromelanin - Toxic or protective molecules? The cellular context makes the difference. 36
NEUROMELANIN ORGANELLES AND AUTOPHAGY IN BRAIN AGING 36
Application of Pump-Probe Imaging Towards Chemical and Structural Characterization of Neuromelanin. 35
The Neuromelanin of Human Substantia Nigra: Physiological and Pathogenic Aspects 35
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. 35
Modeling Midbrain and Brainstem Neuromelanins to Characterize Metal Binding and Associated MRI Contrast in Parkinson's and Alzheimer's Diseases 34
NEUROMELANIN ORGANELLES PATHWAYS AND NEURODEGENERATION IN PARKINSON'S DISEASE 33
Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry 33
Melanin-protein fibrils conjugates as models to study neuromelanin structure and reactivity. 32
α-Synuclein and Dopamine Metabolites DOPAL and DOPAC: A Pathway to New Synthetic Neuromelanin Models 31
Amyloid beta and neuromelanin - Toxic or protective molecules? The cellular context makes the difference. 30
Neuromelanin-sensitive MRI as a proxy-measure of dopamine function in neuropsychiatric illness. 29
Neuromelanins, oxidative stress and Parkinson's disease 28
Neuromelanin and metals in brain aging and neurodegeneration. 28
Iron, copper and their proteins in substantia nigra of human brain during aging. 28
Low iron, high ferritin and high neuromelanin in locus coeruleus neurons. A biochemical profile with relevance to neuronal vulnerability in parkinsonian syndromes. 27
The role of neuromelanin in brain aging and neurodegeneration of Parkinson's disease 27
The application of the Neutron Activation Analysis for trace metals determination in human brain tissues and substantia nigra neuromelanin. 27
Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease 27
NEURONAL MHC-I DISPLAY IN T-CELL MEDIATED NEURODEGENERATION 27
Neuromelanin and metals in brain aging and neurodegeneration. 27
Biosynthetic pathway to neuromelanin and its aging process 26
Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleus 26
Neuromelanin in human brain: protective and toxic role. 26
The role of neuromelanin and iron in brain aging and Parkinson's disease. 26
The relevance of low iron, high ferritin and high neuromelanin to neuronal vulnerability in parkinsonian syndromes. 25
The structure, synthesis and role of neuromelanins in brain aging and neurodegeneration 25
A modern imaging investigation of neuromelanin extracted from the substantia nigra region of the human brain. 24
Chemistry and biophysics of melanins 24
Effect on neurotransmitters and receptors in rat exposed to 50Hz electric and magnetic fields from conception to adult life 24
Low iron, high ferritin and high neuromelanin in locus coeruleus neurons. A biochemical profile with relevance to neuronal vulnerability in parkinsonian syndromes 24
Activation of microglia by neuromelanin: correlation of neuromelanin phagocytosis and degradation, reactive oxygen species production, and ventral midbrain neuron death. 24
The role of neuromelanin in brain aging and Parkinson's disease. 24
MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration 24
Neuromelanin in the human brain: protective and toxic role. 24
Neuromelanin activates microglia and induces substantia nigra neuron death. 24
Iron and copper molecules in aging of human substantia nigra. Consequences for neurodegenerative processes. 23
EXPRESSION OF MHC-I ON SUSBTANTIA NIGRA AND LOCUS COERULEUS OF HUMAN CONTROL and PARKINSON'S DISEASE SUBJECTS: IMPLICATIONS IN DOPAMINERGIC NEURONAL DEGENERATION 23
Effect of prolonged exposure to 50 Hz electric and magnetic fields on neurotransmitters in rat brain 22
Iron, copper and zinc concentration in substantia nigra of human brain during aging. 22
The relevance of low iron, high ferritin and high neuromelanin to neuronal vulnerability in parkinsonian syndromes. 22
Identification and quantification of dolichol and dolichoic acid in neuromelanin from substantia nigra of the human brain 22
Amyloid beta and neuromelanin--toxic or protective molecules? The cellular context makes the difference. 22
The relevance of low iron, high ferritin and high neuromelanin to neuronal vulnerability in parkinsonian syndromes. 22
The role of iron in brain ageing and neurodegenerative disorders 21
The neurodegenerative role of neuromelanin in Parkinson's disease 21
Effetti dell'esposizione cronica a CEM di 50 Hz su neurotrasmettitori e recettori nel cervello di ratto 21
Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics 21
Is neuromelanin of substantia nigra protective or toxic for neurons? 20
NEURONAL MHC-I DISPLAY IN T-CELL MEDIATED NEURODEGENERATION 20
Totale 3.966
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.407
article - articoli 7.400
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 164
Totale 20.971
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202444 0 0 0 0 0 0 0 0 2 0 41 1
2024/20251.618 2 8 136 49 379 46 22 132 49 60 376 359
2025/20262.488 131 348 219 379 467 122 345 151 111 146 69 0
Totale 4.150